Hidetaka Wakabayashi, MD, PhD, Department of Rehabilitation Medicine, Tokyo Women's Medical University Hospital, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, Japan. Code; 162-0054, Tel: +81-3-3353-8111, Fax: +81-3-5269-7639, E-mail:
J Nutr Health Aging. 2021;25(4):507-515. doi: 10.1007/s12603-021-1587-5.
The condition of muscle fiber atrophy and weakness that occurs in respiratory muscles along with systemic skeletal muscle with age is known as respiratory sarcopenia. The Japanese Working Group of Respiratory Sarcopenia of the Japanese Association of Rehabilitation Nutrition narratively reviews these areas, and proposes the concept and diagnostic criteria. We have defined respiratory sarcopenia as "whole-body sarcopenia and low respiratory muscle mass followed by low respiratory muscle strength and/or low respiratory function." Respiratory sarcopenia can be caused by various factors such as aging, decreased activity, undernutrition, disease, cachexia, and iatrogenic causes. We have also created an algorithm for diagnosing respiratory sarcopenia. Respiratory function decreases with age in healthy older people, along with low respiratory muscle mass and strength. We have created a new term, "Presbypnea," meaning a decline in respiratory function with aging. Minor functional respiratory disability due to aging, such as that indicated by a modified Medical Research Council level 1 (troubled by shortness of breath when hurrying or walking straight up hill), is an indicator of presbypnea. We also define sarcopenic respiratory disability as "a disability with deteriorated respiratory function that results from respiratory sarcopenia." Sarcopenic respiratory disability is diagnosed if respiratory sarcopenia is present with functional disability. Cases of respiratory sarcopenia without functional disability are diagnosed as "at risk of sarcopenic respiratory disability." Functional disability is defined as a modified Medical Research Council grade of 2 or more. Rehabilitation nutrition, treatment that combines rehabilitation and nutritional management, may be adequate to prevent and treat respiratory sarcopenia and sarcopenic respiratory disability.
随着年龄的增长,呼吸肌和全身骨骼肌会出现肌肉纤维萎缩和无力的情况,这种情况被称为呼吸肌少肌症。日本康复营养学会呼吸肌少肌症工作组对这些领域进行了叙述性回顾,并提出了概念和诊断标准。我们将呼吸肌少肌症定义为“全身少肌症和呼吸肌质量低,随后出现呼吸肌力量和/或呼吸功能低”。呼吸肌少肌症可由多种因素引起,如衰老、活动减少、营养不足、疾病、恶病质和医源性原因。我们还创建了一种用于诊断呼吸肌少肌症的算法。健康老年人的呼吸功能会随着年龄的增长而下降,同时还会出现呼吸肌质量和力量降低的情况。我们创造了一个新术语,“衰老性呼吸困难”,意思是随着年龄的增长呼吸功能下降。由于衰老导致的轻微功能性呼吸障碍,如改良的医学研究理事会(Medical Research Council)呼吸困难分级 1 级(在快走或直走上坡时呼吸困难),是衰老性呼吸困难的指标。我们还将呼吸肌少肌症引起的呼吸功能恶化定义为“由呼吸肌少肌症引起的呼吸功能障碍”。如果存在呼吸肌少肌症并伴有功能障碍,则诊断为呼吸肌少肌症性呼吸功能障碍。如果存在呼吸肌少肌症但无功能障碍,则诊断为“有发生呼吸肌少肌症性呼吸功能障碍的风险”。功能障碍定义为改良的医学研究理事会呼吸困难分级 2 级或更高。康复营养,即结合康复和营养管理的治疗方法,可能足以预防和治疗呼吸肌少肌症和呼吸肌少肌症性呼吸功能障碍。